Rémy Morgentin

774 total citations
23 papers, 624 citations indexed

About

Rémy Morgentin is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Rémy Morgentin has authored 23 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Rémy Morgentin's work include Quinazolinone synthesis and applications (7 papers), Synthesis and Biological Evaluation (5 papers) and Chemical Synthesis and Analysis (4 papers). Rémy Morgentin is often cited by papers focused on Quinazolinone synthesis and applications (7 papers), Synthesis and Biological Evaluation (5 papers) and Chemical Synthesis and Analysis (4 papers). Rémy Morgentin collaborates with scholars based in France, United Kingdom and Singapore. Rémy Morgentin's co-authors include Patrick A. Plé, Laurent Hennequin, Annie Olivier, Gerard Costello, Richard A. Norman, Michael Fennell, Nicolas Warin, J. Breed, Tim P. Green and Christine Lambert‐van der Brempt and has published in prestigious journals such as Cancer Research, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Rémy Morgentin

21 papers receiving 599 citations

Peers

Rémy Morgentin
Comparison fields: 5 of 69
  • Organic Chemistry 301
  • Molecular Biology 292
  • Oncology 173
  • Pulmonary and Respiratory Medicine 58
  • Hematology 52
Replace Annie Olivier with:
Annie Olivier France
Christine Lambert‐van der Brempt United Kingdom
Venkat R. Pallela United States
Guy Fournet France
Robert H. Gruninger United States
Gerard Costello United Kingdom
Brendan Frett United States
Kimberly G. Petrov United States
Kathleen M. Gillooly United States
Martin Pass United Kingdom
Annie Olivier France View profile →
Citations per field, relative to Rémy Morgentin
Rémy Morgentin · 1×
Citations per year, relative to Rémy Morgentin
Rémy Morgentin · 1×

Countries citing papers authored by Rémy Morgentin

Since Specialization
Citations

This map shows the geographic impact of Rémy Morgentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémy Morgentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémy Morgentin more than expected).

Fields of papers citing papers by Rémy Morgentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémy Morgentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémy Morgentin. The network helps show where Rémy Morgentin may publish in the future.

Co-authorship network of co-authors of Rémy Morgentin

This figure shows the co-authorship network connecting the top 25 collaborators of Rémy Morgentin. A scholar is included among the top collaborators of Rémy Morgentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémy Morgentin. Rémy Morgentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 9
3 10
4 14
5 0
6 2
7 1
8 44
9 2
10 9
11 27
12 283
13
The discovery of AZD0530: a novel, oral, highly selective and dual-specific inhibitor of the Src and Abl family kinases
16
14 31
15 31
16 23
17 16
18 1
19 3
20 30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026